Weill Cornell Medicine, New York Presbyterian Hospital, Department of Gasteroenterology, Department of Surgery, 641 Lexington Ave, New York, NY, 10022, USA.
Weill Cornell Medicine, New York Presbyterian Hospital, Department of Gasteroenterology, Department of Surgery, 641 Lexington Ave, New York, NY, 10022, USA.
Int J Surg. 2019 Jul;67:18-23. doi: 10.1016/j.ijsu.2019.02.010. Epub 2019 Mar 5.
To determine whether clinical evaluation reporting using the IDEAL (Idea, Development, Exploration, Assessment and Long-term study) framework improves a novel double-balloon endoscopic stabilization technology.
Observational registry 6 month study with no follow-up. Using the Prospective Development Study (PDS) format recommended by the IDEAL collaboration, we report on continued refinement and optimization of an endoscopic stabilization platform during a clinical study conducted by two clinicians from the first case onwards. Key outcomes (ability to reach cecum, inflation of balloons in the sigmoid and ascending colon, and complications) were prospectively reported for each patient sequentially. All changes to technique were highlighted, showing when they occurred and an explanation for the change.
30 colonoscopies were undertaken using the device from April to September 2017. Two patients were excluded from the analysis for protocol deviations. Cecum was reached in 89% of the per protocol population of patients in an average time of 13.5 ± 11 min. Therapeutic zone creation was successful in 89% of patients on the right side of the intestine and 100% in those that reached the sigmoid. There were five deliberate changes in technique that occurred during the study that enabled improved device technical performance. There were no serious complications and one polyp was removed successfully using the device. Clinicians reported endoscope stability and increased visibility of the intestinal mucosa increased when using the device.
The IDEAL framework provided a structured reporting of the changes made to technique. Those changes facilitated a device that is safe, has achieved stability with improved performance.
确定使用 IDEAL(理念、开发、探索、评估和长期研究)框架进行临床评估报告是否能改进新型双球囊内镜稳定技术。
无随访的 6 个月观察性注册研究。我们按照 IDEAL 协作推荐的前瞻性发展研究(PDS)格式,报告了从首例患者开始,两名临床医生在临床研究中对内镜稳定平台的持续改进和优化。每位患者的关键结局(到达盲肠的能力、乙状结肠和升结肠球囊充气情况以及并发症)均进行前瞻性连续报告。所有技术变更都被突出显示,展示其发生的时间以及变更的原因。
2017 年 4 月至 9 月期间,共使用该设备进行了 30 例结肠镜检查。两名患者因违反方案被排除在分析之外。在符合方案的患者人群中,89%的患者平均 13.5±11 分钟到达盲肠。在右侧肠道,89%的患者成功创建治疗区,而达到乙状结肠的患者则 100%成功。在研究期间,有 5 次技术上的刻意变更,使设备的技术性能得到改善。没有严重并发症,有一个息肉使用该设备成功切除。临床医生报告说,使用该设备时,内窥镜的稳定性和肠黏膜的可视性增加。
IDEAL 框架提供了对技术变更的结构化报告。这些变更促成了一种安全、稳定且性能得到改善的设备。